F270-0501 Screening compound: ethyl 1-(2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate

F270-0501 Screening compound: ethyl 1-(2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate
F270-0501 Screening compound: ethyl 1-(2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound F270-0501
ethyl 1-(2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F270-0501

Molecular Formula

C17H22N4O5 (C17 H22 N4 O5)

Compound Name

ethyl 1-(2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate

IUPAC name

ethyl 1-(2-{34-dimethyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl}acetyl)piperidine-4-carboxylate

SMILES

CCOC(C(CC1)CCN1C(CN1N=C(C)c2c(C)onc2C1=O)=O)=O

InChI

InChI=1S/C17H22N4O5/c1-4-25-17(24)12-5-7-20(8-6-12)13(22)9-21-16(23)15-14(10(2)18-21)11(3)26-19-15/h12H,4-9H2,1-3H3

InChI Key

WSYMQEJJWVKIIM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111149

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

362.39

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.354

Distribution Coefficient, logD

0.354

Water Solubility, LogSw

-0.49

Polar Surface Area

86.109

Acid Dissociation Constant (pKa)

18.22

Base Dissociation Constant (pKb)

0.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

58.80

F270-0501 in Drug Discovery

Included in Screening Libraries

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with F270-0501 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F270-0501?
Check Price and Availability of F270-0501, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F270-0501 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F270-0501
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F270-0501
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F270-0501 available by request